Daniel Granderson

Compliance and Regulation
Saudi Arabia IVD market rose to $605M in 2022: Kalorama
The market was driven in part by COVID-19 testing, with about 44 million PCR COVID-19 tests performed through last August.
June 19, 2023
Business Financial Results Social
Compliance and Regulation
India IVD market sales rose to $1.4B in 2022: Kalorama Information
According to Kalorama's forecasts, India’s IVD market will increase at a compound annual growth rate (CAGR) of 2.4% from 2022 to 2027.
April 26, 2023
Financials Growth Revenue Business Social
Compliance and Regulation
Mexico IVD sales reach $794M: Kalorama Information
Immunoassays are Mexico’s leading IVD segment, followed by point-of-care and microbiology/molecular. Other POC, other molecular, and flow cytometry will be key segments to watch in coming years.
April 11, 2023
Business Economics Pie Chart Social
Compliance and Regulation
China worth watching in $3.95B world market for molecular POC tests: Kalorama Information
Central and provincial governments have played a significant role in the expansion of the POC testing market in China.
February 22, 2023
Mpoc Figure
Emergency Use Authorization
COVID-19 tests attempt to prove at-home testing concept can work
These COVID-19 tests were granted separate emergency use authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) earlier in 2021 and all require nasal swab specimens from patients.
August 22, 2021
2021 08 18 22 53 0531 Covid 19 Self Swab Test 400
Page 1 of 1
Top Stories
Judge Gavel Court
Lawsuit
Federal judge dismisses pathology group antitrust case
A federal judge has dismissed an antitrust lawsuit filed last year pitting pathology groups Iowa Pathology Associates, Regional Laboratory Consultants, and Goldfinch Laboratory against one another.
Washington Dc Capitol (2)
Policy and Regulation
CAP prioritizes pathologists' needs in 2025
Business Graph Money Stocks Social (1)
Mergers & Acquisitions
$16.5B CDMO deal unhindered by role in broader pharma supply chain
Handcuffs Gavel Social
Compliance and Regulation
Texas lab owner accused of $79M RPP fraud scheme
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Home
Federal judge dismisses pathology group antitrust case
By LabPulse.com staff writers
A federal judge has dismissed an antitrust lawsuit filed last year pitting pathology groups Iowa Pathology Associates, Regional Laboratory Consultants, and Goldfinch Laboratory against one another.
January 23, 2025
Judge Gavel Court
CAP prioritizes pathologists' needs in 2025
By Liz Carey
In a letter to the Trump administration and 119th Congress, the College of American Pathologists (CAP) prioritized the top regulatory, payer, and workforce issues facing anatomic pathologists and their teams in 2025.
January 22, 2025
Washington Dc Capitol (2)
$16.5B CDMO deal unhindered by role in broader pharma supply chain
By Liz Carey
Novo Holdings greenlighted by European Commission to take control of U.S.-based CDMO.
December 11, 2024
Business Graph Money Stocks Social (1)
Texas lab owner accused of $79M RPP fraud scheme
By LabPulse.com staff writers
The DOJ implicated a Texas clinical laboratory owner and operator in respiratory pathogen panel testing fraud scheme.
November 25, 2024
Handcuffs Gavel Social
FDA sounds bacteria alarms over CGMP violations in Maine
By Liz Carey
Tom's troubles highlight the importance of being inspection-ready.
November 21, 2024
Fda Logo V2 Social
Revvity broadens work in newborn testing for NHS England
By LabPulse.com staff writers
Revvity, formerly PerkinElmer, will expand its work with Genomics England to continue the Generation Project.
November 20, 2024
Baby Infant Mom Closeup Social
Roche gets CE Mark for ovarian cancer CDx test
By LabPulse.com staff writers
Roche has received the CE Mark under the European Union's In Vitro Diagnostic Regulation for its companion diagnostic (CDx) test, which is designed to aid in identifying ovarian cancer patients eligible for targeted treatment with Abbvie's Elahere.
November 19, 2024
Ovarian Cancer2 Social
AMP reviews pitfalls of NGS testing for SARS-CoV-2
By Liz Carey
Document offers key pre-analytical, analytical, and post-analytical considerations to help improve NGS-based surveillance programs.
November 15, 2024
Covid Treatment Doctor Social
FDA fall IVD roundtable avoids LDT questions
By Liz Carey
In addition, CAP LDT webinar offers beginning guide for phase one compliance.
November 12, 2024
Diagnostic Analyzer Lab Pcr Social
Lucy Letby murder case flags immunoassays as unreliable for medical evidence
By Liz Carey
At least one pathologist has said it was wrong for scientists representing Liverpool Clinical Laboratories to insist insulin poisoning was the only explanation in a series of high-profile newborn deaths in the U.K., The Telegraph reported.
October 28, 2024
Gavel Handcuffs Proxima Studio
Digital pathology rollouts race for proof-of-concept at national level
By Liz Carey
U.K. invests in clinical trial security while Australia's health minister issues powerful ultimatum.
October 29, 2024
Artificial Intelligence Ai Hand Social
Caris Life Sciences embarks on 10K-sample breast cancer biomarker analysis project
By LabPulse.com staff writers
Caris will perform comprehensive molecular characterization of TAILORx tissue samples.
October 25, 2024
Dna Sequence (1)
Page 1 of 127
Next Page